The intravenous (IV) ibuprofen market continues to offer several therapeutic advantages over other pain management drugs. IV ibuprofen provides rapid and effective pain relief from postoperative pain and, fever and can reduce reliance on opioids. It offers multi-modal benefits and helps in reducing opioid consumption and associated risks. The growing prevalence of surgeries and sports injuries has augmented the demand for more effective postoperative and acute pain management options.
Key Takeaways
Key players operating in the intravenous (IV) ibuprofen market are Cumberland Pharmaceuticals Inc., Hyloris Pharmaceuticals SA, Grifols, S.A., Recordati Rare Diseases Inc., XGEN PHARMACEUTICALS DJB, Inc., AFT Pharmaceuticals, Laboratorios Valmorca, SGPharma Pvt. Ltd., Wellona Pharma, Delex Pharma, Hikma Pharmaceuticals PLC.
The growing incidence of surgeries, sports injuries, and trauma cases has increased the demand for more effective postoperative and acute pain management drugs. Intravenous ibuprofen provides faster and better pain relief than oral medications and reduces the burden on conventional opioids.
Major pharmaceutical companies are focusing on expanding their global footprint through new product approvals and partnerships. In January 2022, Cumberland Pharmaceuticals gained approval to market Iveprazole for Injection in South Korea. In 2021, AFT Pharmaceuticals received approval to sell Ibuprofen Lysine Injection in Australia.
Market Key Trends
One of the key in Intravenous (IV) Ibuprofen Market Size is increasing for non-opioid medications. The opioid crisis and growing addictions have raised alarms regarding the chronic usage of opioids for pain management. This has driven research into novel therapeutic alternatives. IV ibuprofen provides an option for effective postoperative and acute pain relief with relatively lower addiction and safety risks compared to opioids. Growing awareness about these benefits is expected to boost the demand and adoption of IV ibuprofen solutions.
Get More Insights on- Intravenous (IV) Ibuprofen Market
For Deeper Insights, Find the Report in the Language that You want:
